A Comparison of the In Vitro Inhibitory Effects of Thelephoric Acid and SKF-525A on Human Cytochrome P450 Activity |
Song, Min
(College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University)
Do, HyunHee (College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University) Kwon, Oh Kwang (College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University) Yang, Eun-Ju (College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University) Bae, Jong-Sup (College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University) Jeong, Tae Cheon (College of Pharmacy, Yeungnam University) Song, Kyung-Sik (College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University) Lee, Sangkyu (College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University) |
1 | Sridhar, J., Liu, J., Foroozesh, M. and Stevens, C. L. (2012) Insights on cytochrome p450 enzymes and inhibitors obtained through QSAR studies. Molecules 17, 9283-9305. DOI |
2 | Yano, J. K., Hsu, M. H., Griffin, K. J., Stout, C. D. and Johnson, E. F. (2005) Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen. Nat. Struct. Mol. Biol. 12, 822-823. DOI ScienceOn |
3 | Zhou, S. F., Yang, L. P., Zhou, Z. W., Liu, Y. H. and Chan, E. (2009) Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2. AAPS J. 11, 481-494. DOI |
4 | Spatzenegger, M. and Jaeger, W. (1995) Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metab. Rev. 27, 397-417. DOI ScienceOn |
5 | Huang, Z. and Waxman, D. J. (2001) Modulation of cyclophosphamide-based cytochrome P450 gene therapy using liver P450 inhibitors. Cancer Gene Ther. 8, 450-458. DOI |
6 | Hwang, J. S., Song, K. S., Kim, W. G., Lee, T. H., Koshino, H. and Yoo, I. D. (1997) Polyozellin, a new inhibitor of prolyl endopeptidase from Polyozellus multiplex. J. Antibiot. (Tokyo) 50, 773-777. DOI ScienceOn |
7 | Jahng, Y., Kwon, O. K. and Lee, S. (2012) In vitro inhibitory effect of luotonin A on human CYP1A. Arch. Pharm. Res. 35, 2199-2203. 과학기술학회마을 DOI ScienceOn |
8 | Kim, H., Choi, H. K., Jeong, T. C., Jahng, Y., Kim, D. H., Lee, S. H. and Lee, S. (2013) Selective inhibitory effects of mollugin on CYP1A2 in human liver microsomes. Food Chem. Toxicol. 51, 33-37. DOI ScienceOn |
9 | Kwak, J. Y., RHee, I. K., Lee, K. B., Hwang, J. S., Yoo, I. D. and Song, K. S. (1999) Thelephoric acid and kynapcin-9 in mushroom polyozellus multiflex inhibit prolyl endopeptidase in vitro. J. Microbiol. Biotechn. 9, 798-803. 과학기술학회마을 |
10 | Lee, S. K., Kim, G. H., Kim, D. H., Jahng, Y. and Jeong, T. C. (2007) Identification of a tryptanthrin metabolite in rat liver microsomes by liquid chromatography/electrospray ionization-tandem mass spectrometry. Biol. Pharm. Bull. 30, 1991-1995. DOI ScienceOn |
11 | Ono, S., Hatanaka, T., Hotta, H., Satoh, T., Gonzalez, F. J. and Tsutsui, M. (1996) Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica 26, 681-693. DOI |
12 | Porubsky, P. R., Meneely, K. M. and Scott, E. E. (2008) Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates. J. Biol. Chem. 283, 33698-33707. DOI ScienceOn |
13 | Schenkman, J. B., Wilson, B. J. and Cinti, D. L. (1972) Dimethylaminoethyl 2,2-diphenylvalerate HCl (SKF 525-A)--in vivo and in vitro effects of metabolism by rat liver microsomes--formation of an oxygenated complex. Biochem. Pharmacol. 21, 2373-2383. DOI ScienceOn |
14 |
Guidance for Industry Drug interaction Studies - Study Design, Data Analysis, and Implications for Dosing and Labeling (2006). Available at: |
15 | Song, M., Hong, M., Lee, M. Y., Jee, J. G., Lee, Y. M., Bae, J. S., Jeong, T. C. and Lee, S. (2013) Selective inhibition of the cytochrome P450 isoform by hyperoside and its potent inhibition of CYP2D6. Food Chem. Toxicol. 59, 549-553. DOI ScienceOn |
16 | Emoto, C., Murase, S., Sawada, Y., Jones, B. C. and Iwasaki, K. (2003) In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations catalyzed by human cytochrome P450 enzymes: a comparison with SKF-525A and ketoconazole. Drug Metab. Pharmacokinet. 18, 287-295. DOI ScienceOn |
17 | Chang, T. K., Chen, G. and Waxman, D. J. (1995) Modulation of thiotepa antitumor activity in vivo by alteration of liver cytochrome P450-catalyzed drug metabolism. J. Pharmacol. Exp. Ther. 274, 270-275. |
18 | Chung, W. G., Park, C. S., Roh, H. K., Lee, W. K. and Cha, Y. N. (2000) Oxidation of ranitidine by isozymes of flavin-containing monooxygenase and cytochrome P450. Jpn. J. Pharmacol. 84, 213-220. DOI ScienceOn |
19 | Di, Y. M., Chow, V. D., Yang, L. P. and Zhou, S. F. (2009) Structure, function, regulation and polymorphism of human cytochrome P450 2A6. Curr.Drug Metab. 10, 754-780. DOI ScienceOn |
20 | Franklin, M. R. and Hathaway, L. B. (2008) 2-Diethylaminoethyl-2,2-diphenylvalerate-HCl (SKF525A) revisited: comparative cytochrome P450 inhibition in human liver microsomes by SKF525A, its metabolites, and SKF-acid and SKF-alcohol. Drug Metab.Dispos. 36, 2539-2546. DOI ScienceOn |
21 | Guengerich, F. P. (1997) Role of cytochrome P450 enzymes in drug-drug interactions. Adv. Pharmacol. 43, 7-35. DOI |